Fibrosis score consisting of four serum markers successfully predicts pathological fibrotic stages of chronic hepatitis B

This publication has 21 references indexed in Scilit:

• Usefulness of Multiple Biomarkers for the Prediction of Significant Fibrosis in Chronic Hepatitis B
  Journal of Clinical Gastroenterology, 2011
• The role of the non-invasive serum marker FibroTest–ActiTest in the prediction of histological stage of fibrosis and activity in children with naïve chronic hepatitis B infection
  Scandinavian Journal of Infectious Diseases, 2010
• Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients
  Liver International, 2010
• Staging of liver fibrosis in chronic hepatitis B patients with a composite predictive model: A comparative study
  World Journal of Gastroenterology, 2010
• Chronic hepatitis B: Update 2009 #
  Hepatology, 2009
• Double-Contrast MRI for Accurate Staging of Hepatocellular Carcinoma in Patients with Cirrhosis
  American Journal of Roentgenology, 2008
• Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection
  Hepatology, 2006
• Prediction of significant fibrosis in HBeAg‐positive patients with chronic hepatitis B by a noninvasive model†
  Hepatology, 2005
• A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
  Hepatology, 2003
• Serum Type Iii Procollagen Peptide, Type Iv Collagen 7S Domain, Central Triple–Helix of Type Iv Collagen and Tissue Inhibitor of Metalloproteinases in Patients With Chronic Viral Liver Disease: Relationship to Liver Histology
  Hepatology, 1994